comparemela.com

Latest Breaking News On - Company listing application - Page 1 : comparemela.com

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

Company s Listing Application Approved by Nasdaq VICTORIA, BC, April 3, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ; , a clinical-stage biotechnology company leveraging its proprietary.

Eupraxia Pharmaceuticals to Begin Trading on Nasdaq on April 5, 2024

/PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX); (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.